3020 Children's Way
San Diego, CA 92123
Rady Children's Specialists of San Diego
Rady Children's Specialists
Schneider Childrens Hospital GME
Cornell University Medical College
Pediatric Endocrinology, Pediatrics
Dr. Ron Newfield is a pediatric endocrinologist at Rady Children's Hospital-San Diego and a professor of clinical pediatrics at UC San Diego School of Medicine. He is co-director of Rady Children's Gender Management Clinic.
After earning his medical degree at Technion, Institute of Technology in Haifa, Israel, he completed his residency in pediatrics at Schneider Children's Hospital of Long Island Jewish Medical Center, New Hyde Park, N.Y., and his fellowship in pediatric endocrinology at New York Hospital-Cornell Weill College.
Dr. Newfield's clinical interests are thyroid disorders and cancer, adrenal disorders and transgender youth, calcium and bone disorders, and diabetes and lipid disorders. His research interests are type 1 diabetes and prevention, type 2 diabetes, and growth disorders.
His philosophy of care is to treat children in a broad and holistic manner, and to address family and other issues that impact children's health.
Dr. Newfield enjoys teaching the residents and endocrine fellows.
When not working, he enjoys swimming, hiking, skiing and going to watch plays or musicals.
Low vitamin D level in pediatric patients with new onset type 1 diabetes is common, especially if in ketoacidosis.
Al-Zubeidi H, Leon-Chi L, Newfield RS
Pediatric thyroid surgery and management of thyroid nodules - an institutional experience over a 10-year period.
Jiang W, Newbury RO, Newfield RS
Mutational Analysis in Pediatric Thyroid Cancer and Correlations with Age, Ethnicity, and Clinical Presentation.
Nikita ME, Jiang W, Cheng SM, Hantash FM, McPhaul MJ, Newbury RO, Phillips SA, Reitz RE, Waldman FM, Newfield RS
Bone maturation along the spectrum from normal weight to obesity: a complex interplay of sex, growth factors and weight gain.
Klein KO, Newfield RS, Hassink SG
A 4-Year, Open-Label, Multicenter, Randomized Trial of GenotropinÂ® Growth Hormone in Patients with Idiopathic Short Stature: Analysis of 4-Year Data Comparing Efficacy, Efficiency, and Safety between an Individualized, Target-Driven Regimen and Standard Dosing.
Counts DR, Silverman LA, Rajicic N, Geffner ME, Newfield RS, Thornton P, Carakushansky M, Escobar O, Rapaport R, Levitsky L, Rotenstein D, Hey-Hadavi J, Wajnrajch MP
Evaluation of the American-English Quality of Life in Short Stature Youth (QoLISSY) questionnaire in the United States.
Bullinger M, Sommer R, Pleil A, Mauras N, Ross J, Newfield R, Silverman L, Rohenkohl A, Fox J, Quitmann J
Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes.
Thurber BW, Carmody D, Tadie EC, Pastore AN, Dickens JT, Wroblewski KE, Naylor RN, Philipson LH, Greeley SA, United States Neonatal Diabetes Working Group.
The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months.
Sosenko JM, Skyler JS, Beam CA, Boulware D, Mahon JL, Krischer JP, Greenbaum CJ, Rafkin LE, Matheson D, Herold KC, Palmer JP, Type 1 Diabetes TrialNet and Diabetes Prevention Trialâ€“Type 1 Study Groups.
Successful use of long acting octreotide in two cases with Beckwith-Wiedemann syndrome and severe hypoglycemia.
Al-Zubeidi H, Gottschalk ME, Newfield RS
Lipoprotein particle concentrations in children and adults following Kawasaki disease.
Lin J, Jain S, Sun X, Liu V, Sato YZ, Jimenez-Fernandez S, Newfield RS, Pourfarzib R, Tremoulet AH, Gordon JB, Daniels LB, Burns JC
Codon Arg15 mutations of the AP2S1 gene: common occurrence in familial hypocalciuric hypercalcemia cases negative for calcium-sensing receptor (CASR) mutations.
Hendy GN, Canaff L, Newfield RS, Tripto-Shkolnik L, Wong BY, Lee BS, Cole DE
A four-year, open-label, multi-center, randomized, two-arm study of GenotropinÂ® in patients with idiopathic short stature: comparison of an individualized, target-driven treatment regimen to standard dosing of GenotropinÂ® - analysis of two-year data.
Counts DR, Silverman LA, Geffner ME, Rajicic N, Hey-Hadavi J, Thornton PS, Wajnrajch MP, ISS Study Group.
Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants.
Sosenko JM, Skyler JS, Beam CA, Krischer JP, Greenbaum CJ, Mahon J, Rafkin LE, Matheson D, Herold KC, Palmer JP, Type 1 Diabetes TrialNet and Diabetes Prevention Trialâ€“Type 1 Study Groups.
The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients.
Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Yu L, Mahon J, Beam CA, Boulware DC, Rafkin L, Schatz D, Eisenbarth G, Type 1 Diabetes TrialNet Study Group., Diabetes Prevention Trial-Type 1 Study Group.
Self-limiting hematuria following growth hormone provocative testing with arginine hydrochloride.
Marinkovic M, Newfield RS
Third-trimester pregnancy complications.
Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.
Hey-Hadavi J, Pleil A, Deeb LC, Fuqua JS, Silverman LA, Reiner B, Newfield R, Rajicic N, Wajnrajch MP, Cara JF
Postoperative cognitive dysfunction.
Rapid weight gain in children soon after diagnosis of type 1 diabetes: is there room for concern?
Newfield RS, Cohen D, Capparelli EV, Shragg P
See the full listing of this physician's publications on PubMed, a service of the National Library of Medicine.
PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.